Breast Carcinoma, Intratumour Heterogeneity and Histological Grading, Using Geostatistics
نویسندگان
چکیده
منابع مشابه
Breast Carcinoma, Intratumour Heterogeneity and Histological Grading, Using Geostatistics
Tumour progression is currently believed to result from genetic instability. Chromosomal patterns specific of a type of cancer are frequent even though phenotypic spatial heterogeneity is omnipresent. The latter is the usual cause of histological grading imprecision, a well documented problem, without any fully satisfactory solution up to now. The present article addresses this problem in breas...
متن کاملA Comparative and Evaluative Study of Two Cytological Grading Systems in Breast Carcinoma with Histological Grading: An Important Prognostic Factor
OBJECTIVE Cytonuclear gradings in the breast carcinoma raise the level of FNA reportage and improves patient management. Our aim was to evaluate and compare two cytological grading methods (Robinson's and Mouriquand's) in breast carcinoma and correlate it with Nottingham modification of Scarff-Bloom-Richardson (SBR) histological grading. MATERIALS AND METHODS 30 cytologically proven cases of ...
متن کاملInvestigating intratumour heterogeneity by single-cell sequencing.
Intratumour heterogeneity is a longstanding field of focus for both researchers and clinicians. It refers to the diversity amongst cells within the same tumour. Two major hypotheses have attempted to explain the existence of intratumour heterogeneity: (i) the clonal evolution (CE) theory and (ii) the cancer stem cell (CSC) model. CE theory emphasizes the evolutionary biological characteristics ...
متن کاملSystematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
BACKGROUND Candidate biomarkers have been identified for clear cell renal cell carcinoma (ccRCC) patients, but most have not been validated. OBJECTIVE To validate published ccRCC prognostic biomarkers in an independent patient cohort and to assess intratumour heterogeneity (ITH) of the most promising markers to guide biomarker optimisation. DESIGN, SETTING, AND PARTICIPANTS Cancer-specific ...
متن کاملInter and Intratumour Heterogeneity: A Barrier to Individualized Medical Therapy in Renal Cell Carcinoma?
Medical therapy for rcc in 2012 There are nearly 9000 new diagnoses of renal cell carcinoma (RCC) each year in the United Kingdom, and nearly 60,000 in the United States (Jemal et al., 2010; UK, 2011; Jemal et al., 2010; Cancer Research UK, 2011). Nephrectomy for localized disease may be curative, but ∼50% of patients present with or subsequently develop metastatic disease (Motzer et al., 1996;...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Analytical Cellular Pathology
سال: 2000
ISSN: 0921-8912,1878-3651
DOI: 10.1155/2000/164360